Sign in

CIK 0001650648 · Non-accelerated filer<br>Smaller reporting company

4D Molecular Therapeutics, Inc.

Sign in to watch
Ticker
FDMT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
473506994
Phone
5105052680
Business address
5858 HORTON STREET #455, EMERYVILLE, CA, 94608
Former names
4D Molecular Therapeutics Inc., 4D Molecular Therapeutics Inc
  1. 4 Derivatives Options or other derivatives
  2. 8-K Event Results of operations
  3. 10-Q Report Quarterly Report
  4. EFFECT Other Notice of Effectiveness
  5. CORRESP Other Correspondence Between Filers and SEC Staff
  6. DEFA14A Proxy Proxy Materials
  7. DEF 14A Proxy Proxy Statement
  8. UPLOAD Other SEC-generated Letter
  9. 3 Insider Initial Statement of Ownership
  10. S-3 Offering Registration Statement
  11. S-8 Other Securities Offered to Employees in Benefit Plans
  12. 10-K Report Annual Report
  13. 8-K Event Results of operations
  14. 8-K Event Executive or director change
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. SC 13G/A Stake Amended Statement of Ownership
  19. SC 13G/A Stake Amended Statement of Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 17 of 23 · 442 filings